Kedrion Announces Safer Manufacture Process for Koate Antihemophilic Factor

Note: This is an edited version of a Kedrion press release. To read the full release, click here. ____________________Kedrion Biopharma proudly announced that Koate® Double Viral Inactivation (DVI) Antihemophilic Factor (human) is now being manufactured using a process that further enhances the safety and purity of that product. Koate-DVI is used in the treatment of hemophilia […]